Medizinische Hochschule Hannover (Hannover Medical School)

The Hannover Medical School (Medizinische Hochschule Hannover, MHH) is one of leading universities in research, patient care and teaching. With its concentrated support of specialised research areas, it is one of the finest university clinics in the country, and Germany's only institution of higher education devoted exclusively to medicine. Founded in 1965, MHH is also the only medical university (faculty) in Germany operating under a true ‘Integration Model’. Under this model, the clinical and diagnostic laboratory services of a large university hospital and medical university are run under one administrative structure with a unified budget. 

Every year, more than 60,000 inpatients and well over 450,000 outpatients are treated at the MHH, which provides a full range of treatment and care of the highest quality. In no other university clinic in Germany are patients with such severe conditions treated as they are in the 18 medical centres and 75 departments on the MHH campus. The MHH is also a pioneer in transplant medicine and is one of the world's leading transplant centres. 400 to 500 organ transplants are performed yearly, more than anywhere else in Germany. The MHH is one of the world leaders in lung transplants and ECMO treatment. In addition, 140 to 170 bone marrow and blood stem cell transplants are handled every year. Moreover, the MHH has a leading position in cochlear implants, electronic inner ear stimulating devices. Each year, 500 patients are supplied with one of these devices, enabling them to hear again – or for the first time.

The MHH is also a leader in research, as is clear from the number of interdisciplinary projects and the volume of funding acquired: in 2019, this amounted to ~80 million euro. This success was made possible by the more than 1,600 scientists and nearly 33,650 square meters of laboratory space at the MHH. Among the research institutions at the MHH are the research network REBIRTH for regenerative medicine, the Integrated Research and Treatment Centre Transplantation (IFB-Tx), 55 research projects within the 7 Framework Programme of the European Union, six DFG Collaborative Research Centres (CRC), four DFG Research Groups, one DFG Priority Programme, one European Research Training Programme, and hundreds of other research projects. Furthermore, the Federal Government is currently establishing six German Centres for Health Research to pool research into a number of particularly important common diseases. Researchers of the MHH will contribute to two of these centres: the German Centre for Infection Research and the German Centre for Lung Research.

The major research areas of the MHH are Immunity & Infection; Implant Research & Biomedical Technology; Transplantation and Regeneration. The MHH is a leader in the research of Infection and Immunity, cooperating with the Helmholtz Centre for Infection Research in Braunschweig. Both are members of TRAIN, a cross-disciplinary alliance of university and non-university research institutes in the Hannover/Braunschweig area, funded by the Ministry of Science and Culture of the German State of Lower Saxony. Within TRAIN, know-how and infrastructure are being pooled, so as to accelerate the transfer of new candidate drugs and vaccines from bench to bedside. Interdisciplinary cooperation is the major aim of the MHH - within and beyond the borders of the Campus - in the Clinic and in Research. 

The Excellence Initiative of the federal and state governments recognised the exceptional research potential present at the MHH: REBIRTH for Regenerative Medicine is based on the work of outstanding research groups, particularly those dedicated to stem cell research, to engineering of heart, lung, liver and blood tissue, and to biohybrid devices. More than 110 scientists are working at the Hans Borst Research Centre for Heart and Stem Cell Research, which is located directly next to the Transplant Research Centre.

With its Integrated Research and Treatment Centre Transplantation (IFB-Tx) the MHH strengthened its role as the leading institution for transplant research, which has made possible more rapid clinical application of research results.

At MHH, there are about 167 positions at the senior academic level (full, associate, assistant professors) and about 2,430 permanent positions for medical doctors and scientists.

The MHH is internationally renowned for excellence in patient care, research and teaching. There is great demand by students, physicians and scientists from all over the world to come to Hannover to study, work and conduct research. International cooperative agreements and networks are constantly being expanded with other universities and clinics worldwide. Furthermore, the MHH organises internships and foreign study semesters for its students. People from more than 40 countries study, work and research at the MHH, which is thus one of the most international workplaces in the capital of Lower Saxony.

More than 3,400 students are currently enrolled at the MHH: in medicine or dentistry as undergraduates or in a doctoral or other advanced degree programme. Since 2006, a innovative medical curriculum is established: "HannibaL", an acronym for the Hannover Medical School's integrated, professionally oriented, adaptive course of study. All coursework focuses on practical application. From the very first week, students are in direct contact with patients. Each year, three tenweek modules covering the same subject matter are offered in parallel (from October to December, January to March, and April to July). The year's students are assigned to three groups, so that only one third of the students is enrolled in a module at a given time.

The MHH founded the Hannover Biomedical Research School (HBRS) to recruit and keep the best young scientists. This graduate school represents an “umbrella organisation” for existing and future structured postgraduate programmes – mainly PhD programmes and Research Training Groups (GKs). It coordinates teaching and ensures excellent training in high quality research laboratories, furthers motivation, and actively encourages integration and interdisciplinary exchange between students and young researchers from both medical and life science backgrounds. A joint HBRS curriculum was established, and the excellent quality of the various training programmes was confirmed, when the DAAD acclaimed the MHH's MD/PhD programme Molecular Medicine as “Best-practise program”. In addition, HBRS was successful in the national Excellence Initiative as well.

The MHH is the best provider of childcare arrangements among all universities in Germany, with places for 375 boys and girls between the ages of eight months (150) and ten years, and this service is constantly being expanded. Childcare is also available in emergency situations. The MHH Mentoring Programme for Women was established to help women structure and plan their scientific careers. The MHH is certified by the Hertie Foundation “Family Friendly University” that confirmed the quality of its family orientated services. 

The MHH provides occupational training for nearly 500 young people in its five schools of healthcare professions. Furthermore, up to 60 apprentices receive training at the MHH to learn a wide range of trades regulated by the medical association, such as physician's assistant, medical data specialist, animal handler, dental technician and more.

The German Federation started a programme to support “Voluntary Services”. The MHH joint this programme and initiated “Voluntary Scientific Year” supported by REBIRTH as well as the Graduate School HBRS. Each year about 40 High-School graduates start a scientific internship in one of the MHH‘s or Leibniz University Hannover laboratories .

For further information on the MHH please visit its website.

Leibniz University of Hannover (LUH)

“Shaping the future with knowledge” – this is the guiding principle of Leibniz Universität Hannover. Founded in 1831 as a trading school in the kingdom of Hannover, the university today comprises nine faculties and one Leibniz Research School with the rank of a faculty. The study programmes cover engineering, natural sciences, landscape science, architecture, economics, law, social sciences, and the humanities. Leibniz Universität Hannover offers more than 170 fulltime and part-time study programmes for degrees at various levels.


Faculty of Architecture and Landscape Sciences
Faculty of Civil Engineering and Geodetic Science
Faculty of Economics and Management
Faculty of Electrical Engineering and Computer Science
Faculty of Humanities
Faculty of Law
Faculty of Mathematics and Physics
Faculty of Mechanical Engineering
Faculty of Natural Sciences
QUEST Leibniz Research School

The academic staff includes 326 professors who are in charge of the academic teaching of 27,625 students, 11% of whom are international students who have received their certificate for university entrance in a foreign country. The proportion of female students acquiring a degree at Leibniz Universität in the winter term of 2016/17 was 46%. Overall, 36% of the 340 dissertations for a doctoral degree in 2015 were submitted by women. Leibniz Universität considers gender equality a central aspect for the future development of science. Therefore, the appointment of female professors is at the core of the university’s research strategy. Moreover, there were more than 2,600 researchers at Leibniz Universität in 2016, of whom 692 (31%) were women.

The university’s budget in 2015 was 447.2M Euro, which included 104.8M Euro in third-party funding. In 2015, we received a total of 39.5M Euro funding from the German Research Foundation (DFG). Scientists at the Leibniz Universität currently coordinate six DFG-funded Collaborative Research Centres (CRC) and participate in two additional CRC/Transregios. Further DFG-funded research includes two Research Units (RU) and five Research Training Groups (RTG) hosted at the Leibniz Universität, participation in four additional RTGs, and the coordination of three Priority Programmes (PP).

Since the launch of the ERC Grant programme in 2007, twelve researchers from the Leibniz Universität have received ERC Grants. Currently, we host five scientists working on projects funded by an ERC Starting Grant or ERC Advanced Grant. Additionally, two international Sofja Kovalevskaja Award winners have chosen to establish working groups at the Leibniz Universität since 2012. In the EU Framework Programme for Research and Innovation HORIZON 2020 (2014-2020), the Leibniz Universität has been awarded almost 10.8M Euro to date for the coordination of two collaborative research projects and participation in 27 additional projects.

Part of this success can be traced to an innovative and progressive organisational structure which enables our scientists to establish and pursue cutting-edge research across traditional disciplinary and faculty boundaries. Research Initiatives (RI) investigate clearly defined research topics with an interdisciplinary scope. Research Centres (RC), which are characterised by a considerable degree of international and scientific visibility, receive financial support from the university management and undergo an external review process. Finally, Leibniz Research Schools (RS) provide a flexible structure for cross-faculty, internationally excellent research. The Cluster of Excellence QUEST became the first Leibniz Research School in 2009. In 2016, the Leibniz School of Education was established with a similar organisational status to QUEST, focusing on the coordination of teacher training at the Leibniz Universität Hannover.

The Leibniz Universität Hannover avails of a wide range of research facilities, equipment and resources. Over the last ten years, the university, with the support of the State of Lower Saxony, the federal government, and the European Union, has invested ca. 350M Euro into new buildings and existing research infrastructure to offer our scientists the best possible research environment. We have 33,500 m² of laboratory space, including 1,600 m² cleanroom facilities. Our outstanding, state-of-the-art facilities include the Centre of Biomolecular Drug Research (BMWZ), the Laboratory of Nano and Quantum Engineering, a new campus for the Faculty of Mechanical Engineering, currently under construction and due for completion in 2019, and the Hannover Institute of Technology (HITec) which will open in 2018, providing a unique cross-disciplinary research facility for quantum technologies. The university also acknowledges the importance of open science and has adopted a research data management policy, flanked by bespoke advisory services and the appropriate technical infrastructure.

We attribute our research success to exceptional individual achievements arising from our interdisciplinary research clusters and to our extensive cooperation with international, national and regional partners. Our most important regional university partners are Hannover Medical School, the University of Oldenburg, and the Technische Universität Braunschweig. A strategic alliance between the Leibniz Universität and the TU Braunschweig (Wissenschaftsallianz Braunschweig-Hannover) is supported by the State of Lower Saxony with 27M Euro in funding over a period of five years. This alliance aims to strengthen and expand the combined research excellence of the partners in the fields of quantum metrology, mobility, and life sciences through joint strategic measures.

The Leibniz Universität cooperates with several scientific institutions and organisations such as the Fraunhofer Society with the establishment of the Institute for Wind Energy and Energy System Technology (IWES). IWES and Leibniz Universität are members of a consortium which has applied for a cluster formed by business and science in the Leading-Edge Cluster Competition of the Federal Ministry of Education and Research. This consortium named WindPowerCluster has been asked to submit a full proposal in autumn 2011.

For further information on the LUH please visit its website.

Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover (ITEM)

The Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM) is an institution of the Fraunhofer Society for the Advancement of Applied Research (FhG). The spectrum of research and development activities includes preclinical/clinical pharmacological research and development, allergy and asthma research, and investigations into tissue and environmental toxicology and consumer protection, as well as the testing and registration of chemicals, biocides and pesticides. As a member of the Fraunhofer Society with its focus on translational research, ITEM generates more than 50 % of its budget from industrial contacts. ITEM’s priority area of interest is diseases and disorders of the respiratory tract, and it has established a unique platform for molecular toxicology (with approved laboratories). This includes animal experiments using high-performance imaging techniques, a cell processing laboratory that works to good manufacturing practice (GMP) standards, and a clinical unit that is able to apply GMP in pulmonology. The ITEM has also collaborated successfully with the MHH, the LUH and the HZI for many years.

For further information on the ITEM please visit its website.

Helmholtz Centre for Infection Research, Braunschweig (HZI)

The Helmholtz Centre for Infection Research (HZI) is a non university research institution with more than 600 staff. An important player in the Helmholtz Association, the HZI has placed its scientific focus on infection research. The main theme around which the participating researchers’ work revolves is the complex interplay between infection pathogens and the immune system. There are numerous successful research ties with MHH, especially with all of its present collaborative research centres (SFBs). The HZI’s involvement is quite crucial for the fields of immunology and cell biology and for associated technology platforms such as genomics, proteomics, mouse genetics, development of good manufacturing practice (GMP) and the production of proteins, cell and gene therapy products, and in vivo imaging. The HZI and the MHH receive joint funding from the DFG, the BMBF, the EU, and the Bill and Melinda Gates Foundation.

For further information on the HZI please visit its website.

Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute (FLI), Mariensee

The Friedrich-Loeffler-Institute (FLI), Germany’s Federal Research Institute of Animal Health, is an independent higher federal authority run under the aegis of the German Federal Ministry of Food and Agriculture (BMEL).The main task is to promote and monitor the health of farm animals and protecting people from infections that can be transmitted from animals to humans (zoonoses).The FLI has 11 institutes on five different sites. The Mariensee site (approximately 30 km northwest of Hannover) is home to the Institute of Farm Animal Genetics.

Prominent research projects at the Mariensee laboratories with connection to Rebirth relate to the production and the characterization of transgenic pigs for xenotransplantation research, to produce large animal models, or for studies on cell reprogramming by somatic cell nuclear transfer based on cloning. Another important issue is the development of suitable culture systems for maintenance of pluripotent stem cells mainly in pigs. The Institute of Farm Animal Genetics has enjoyed long and successful cooperation with MHH (in the form of a collaborative research centre). The Institute has unique expertise relating to large-animal models and tissue regeneration. These aspects are of great importance for the development of innovative approaches to cell therapy and tissue engineering, and their comparative evaluation.

For further information on the FLI please visit the website.

Laser Zentrum Hannover e.V. (LZH)

On June 20, 1986 the Laser Zentrum Hannover e.V. (LZH) was founded under the patronage of the German State Ministry of Trade, Industry, Technology, and Transportation in Lower Saxony. The main task of the LZH is to support applied research in laser technology on a non-profit basis. The LZH is involved in: 

  • R&D projects in the field of laser development and laser applications
  • Technical and scientific consulting to link research and practice
  • Industry-oriented training of experts for applying and operating laser systems

 Through the close cooperation between production engineers, material scientists, and physicists the scientists of the LZH find interdisciplinary solutions for all fields of laser applications.

For further information on the LZH please visit its website.


Max Planck Institute for Molecular Biomedicine, Münster (MPI)

More than 150 scientists from over 15 countries are engaged in research at the Max Planck Institute for Molecular Biomedicine (MPI). The institute, founded in 2001, comprises three departments:

• Vascular cell biology;
• Cell and developmental biology; and
• Tissue biology and morphogenesis.

One of the MPI’s chief research focuses is on the molecular biology of pluripotent stem cells and germline development. This involves strategies for reprogramming somatic cells into a pluripotent state by means of somatic cell nucleus transfer or other techniques such as cell fusion. One of the main aims is to discover factors and complexes that modify chromatin and histones during the reprogramming process. A further area of expertise consists in the differentiation of germ cells from pluripotent cells, as with the in vitro production of oocytes (egg cells) from ES cells. Many national and international collaborations have been firmly established, including those with the Institute of Farm Animal Genetics Mariensee and MHH.

For more information on the MPI please visit the website.

University of Veterinary Medicine Hannover, Foundation (TiHo)

The University of Veterinary Medicine Hannover, Foundation (TiHo) is run under the auspices of a public foundation. Founded in 1778, today it is the oldest independent college of veterinary medicine in Germany and numbers among the most renowned veterinary educational institutions worldwide. The TiHo has close ties with both the LUH and MHH. The participating departments combine clinical diagnostics and therapeutic procedures with innovative research in biomedicine and biomedical engineering. In this connection, various interdisciplinary collaborative ventures between clinical research and technically oriented fields have emerged. The TiHo has unique expertise in diagnostic and therapy models, which are of great importance as models for diseases and disorders in humans. The Small Animal Clinic, for example, is able to integrate both in vivo and in vitro approaches, utilizing its know-how in different molecular methods, cell cultures and investigative techniques (relating to animal breeding and surgical procedures), the use of special equipment (such as micro-CT scanners and fluorescence microscopes) and multiple clinical studies.

For further information on the TiHO please visit its website.

This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree